Sanofi (France)

JOBS

IN THE PRESS

Press Releases

Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration

September 11, 2025

·

6 min read

Press Releases

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis

September 4, 2025

·

9 min read

Press Releases

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site

September 3, 2025

·

4 min read

Press Releases

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia

September 1, 2025

·

10 min read

Press Releases

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease

August 14, 2025

·

6 min read

Press Releases

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.

August 6, 2025

·

5 min read

Press Releases

Arrowhead Subsidiary Visirna Sells Rights to Hypertriglyceridemia Candidate Plozasiran in Greater China to Sanofi

August 4, 2025

·

8 min read

Press Releases

Press release: Online availability of Sanofi’s half-year financial report for 2025

August 1, 2025

·

1 min read

Press Releases

Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma

July 30, 2025

·

6 min read

Press Releases

Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma

July 25, 2025

·

10 min read